Why is Saroja Pharma In falling/rising?

As of 24-Sep, Saroja Pharma Industries India Ltd's stock price is flat at 46.00, showing no change (0.00%). The stock has underperformed in the short term, with a 1-week return of -2.23% compared to the Sensex's -1.08%. Over the past month, the stock has declined by 17.12%, while the Sensex has gained 0.75%. Additionally, the stock's year-to-date performance is down 23.33%, contrasting with the Sensex's increase of 5.97%. Today's price summary indicates that the stock has outperformed its sector by 0.45%, but it is experiencing a decline in investor participation, with delivery volume dropping by 37.5% against the 5-day average. The stock is trading above its 50-day, 100-day, and 200-day moving averages, but below its 5-day and 20-day moving averages, suggesting mixed technical signals.
In the broader market context, Saroja Pharma's recent performance highlights a significant divergence from the benchmark indices. While the stock has struggled with substantial losses over the past month and year, the Sensex has shown resilience with positive returns. This contrast indicates that investor sentiment towards Saroja Pharma may be negatively affected by broader market trends, despite its recent outperformance against its sector. The liquidity of the stock remains adequate for trading, but the falling delivery volume suggests a potential decrease in investor interest, which could further impact its price movement negatively in the near term.